Bezuclastinib
cogent biosciences
['apex']
#cogentbiosciences presents preclinical data at #aacr23 highlighting precision therapy pipeline and announces initiation of part 2 of the registration-enabling apex trial with #bezuclastinib in advanced systemic #mastocytosis $cogt 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.